Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.03
NYSE:SEM's Cash to Debt is ranked lower than
91% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. NYSE:SEM: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:SEM' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: N/A
Current: 0.03
Equity to Asset 0.20
NYSE:SEM's Equity to Asset is ranked lower than
85% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. NYSE:SEM: 0.20 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:SEM' s Equity to Asset Range Over the Past 10 Years
Min: -0.09  Med: 0.25 Max: 0.32
Current: 0.2
-0.09
0.32
Interest Coverage 2.00
NYSE:SEM's Interest Coverage is ranked lower than
83% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 7.52 vs. NYSE:SEM: 2.00 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:SEM' s Interest Coverage Range Over the Past 10 Years
Min: 1.35  Med: 2.27 Max: 3.55
Current: 2
1.35
3.55
F-Score: 5
Z-Score: 1.63
M-Score: -2.63
WACC vs ROIC
8.39%
5.88%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.03
NYSE:SEM's Operating margin (%) is ranked higher than
51% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 6.97 vs. NYSE:SEM: 7.03 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:SEM' s Operating margin (%) Range Over the Past 10 Years
Min: 7.03  Med: 10.01 Max: 13.93
Current: 7.03
7.03
13.93
Net-margin (%) 3.47
NYSE:SEM's Net-margin (%) is ranked lower than
57% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.69 vs. NYSE:SEM: 3.47 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:SEM' s Net-margin (%) Range Over the Past 10 Years
Min: 1.04  Med: 3.67 Max: 5.12
Current: 3.47
1.04
5.12
ROE (%) 16.17
NYSE:SEM's ROE (%) is ranked higher than
73% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 9.37 vs. NYSE:SEM: 16.17 )
Ranked among companies with meaningful ROE (%) only.
NYSE:SEM' s ROE (%) Range Over the Past 10 Years
Min: 10.2  Med: 15.37 Max: 19.74
Current: 16.17
10.2
19.74
ROA (%) 3.24
NYSE:SEM's ROA (%) is ranked lower than
56% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. NYSE:SEM: 3.24 )
Ranked among companies with meaningful ROA (%) only.
NYSE:SEM' s ROA (%) Range Over the Past 10 Years
Min: 0.88  Med: 3.75 Max: 5.36
Current: 3.24
0.88
5.36
ROC (Joel Greenblatt) (%) 35.38
NYSE:SEM's ROC (Joel Greenblatt) (%) is ranked higher than
70% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 19.96 vs. NYSE:SEM: 35.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:SEM' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 35.14  Med: 44.82 Max: 75.33
Current: 35.38
35.14
75.33
Revenue Growth (3Y)(%) 11.40
NYSE:SEM's Revenue Growth (3Y)(%) is ranked higher than
66% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. NYSE:SEM: 11.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:SEM' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 0.9 Max: 13.1
Current: 11.4
0
13.1
EBITDA Growth (3Y)(%) 4.90
NYSE:SEM's EBITDA Growth (3Y)(%) is ranked lower than
62% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. NYSE:SEM: 4.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:SEM' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -1.55 Max: 12.9
Current: 4.9
0
12.9
EPS Growth (3Y)(%) -1.90
NYSE:SEM's EPS Growth (3Y)(%) is ranked lower than
72% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. NYSE:SEM: -1.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:SEM' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 8.6 Max: 98.9
Current: -1.9
0
98.9
» NYSE:SEM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

SEM Guru Trades in Q3 2015

Jim Simons 160,322 sh (New)
Paul Tudor Jones 47,900 sh (+183.43%)
Chuck Royce 164,000 sh (+19.27%)
David Dreman 876,534 sh (+14.18%)
Ken Fisher 3,908,019 sh (+1.19%)
» More
Q4 2015

SEM Guru Trades in Q4 2015

Louis Moore Bacon 481,000 sh (New)
Steven Cohen 851,200 sh (New)
Ken Fisher 4,808,730 sh (+23.05%)
Chuck Royce 190,000 sh (+15.85%)
George Soros 307,500 sh (unchged)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
David Dreman 830,862 sh (-5.21%)
» More
Q1 2016

SEM Guru Trades in Q1 2016

Paul Tudor Jones 21,200 sh (New)
Steven Cohen 1,648,100 sh (+93.62%)
David Dreman 878,435 sh (+5.73%)
Chuck Royce 197,500 sh (+3.95%)
George Soros 307,500 sh (unchged)
Louis Moore Bacon Sold Out
Ken Fisher 4,808,263 sh (-0.01%)
» More
Q2 2016

SEM Guru Trades in Q2 2016

Paul Tudor Jones 30,000 sh (+41.51%)
Chuck Royce 200,000 sh (+1.27%)
Ken Fisher 4,834,631 sh (+0.55%)
Steven Cohen Sold Out
David Dreman Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SEM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:SCAI, NAS:AMED, NYSE:AHS, NYSE:THC, NYSE:CYH, NYSE:CHE, NAS:PAHC, NYSE:ADPT, NAS:SGRY, NAS:HWAY, NAS:LPNT, NYSE:USPH, NAS:LHCG, NAS:PRSC, OTCPK:LTGHY, OTCPK:MFCSF, NYSE:AAC, NAS:AFAM, OTCPK:HHCSY, NAS:BIOS » details
Traded in other countries:S24.Germany,
Select Medical Holdings Corp provides long term acute care hospital services and inpatient acute rehabilitative hospital care and provides physical, occupational and speech rehabilitation services.

Select Medical Holdings Corp was formed in December 1996. The Company provides long term acute care hospital services and inpatient acute rehabilitative hospital care through its specialty hospital segment and provides physical, occupational and speech rehabilitation services through its outpatient rehabilitation segment. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. The Company's specialty hospital segment consists of hospitals designed to serve the needs of long term stay acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. Patients are admitted to the Company's specialty hospitals from general acute care hospitals. These patients have specialized needs, and serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders and cancer. The Company's outpatient rehabilitation segment consists of clinics and contract services that provide physical, occupational and speech rehabilitation services. The Company's outpatient rehabilitation patients are diagnosed with musculoskeletal impairments that restrict their ability to perform normal activities of daily living. As of December 31, 2013, the Company operated 123 specialty hospitals in 28 states, and 1,006 outpatient rehabilitation clinics in 32 states and the District of Columbia. It also provide medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites. The Company competes with Kindred Healthcare Inc., HealthSouth Corporation, Physiotherapy Associates and U.S. Physical Therapy among others. Its healthcare facilities are subject to state and local licensing regulations.

Ratios

vs
industry
vs
history
P/E(ttm) 11.41
SEM's P/E(ttm) is ranked higher than
87% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 24.63 vs. SEM: 11.41 )
Ranked among companies with meaningful P/E(ttm) only.
SEM' s P/E(ttm) Range Over the Past 10 Years
Min: 7.58  Med: 13.08 Max: 25.23
Current: 11.41
7.58
25.23
Forward P/E 15.15
SEM's Forward P/E is ranked higher than
68% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 17.86 vs. SEM: 15.15 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 11.41
SEM's PE(NRI) is ranked higher than
89% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 25.18 vs. SEM: 11.41 )
Ranked among companies with meaningful PE(NRI) only.
SEM' s PE(NRI) Range Over the Past 10 Years
Min: 7.58  Med: 13.08 Max: 25.23
Current: 11.41
7.58
25.23
Price/Owner Earnings (ttm) 9.12
SEM's Price/Owner Earnings (ttm) is ranked higher than
85% of the 88 Companies
in the Global Medical Care industry.

( Industry Median: 25.21 vs. SEM: 9.12 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
SEM' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.43  Med: 18.95 Max: 145.31
Current: 9.12
6.43
145.31
P/B 1.74
SEM's P/B is ranked higher than
67% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. SEM: 1.74 )
Ranked among companies with meaningful P/B only.
SEM' s P/B Range Over the Past 10 Years
Min: 1.09  Med: 1.69 Max: 2.87
Current: 1.74
1.09
2.87
P/S 0.38
SEM's P/S is ranked higher than
88% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. SEM: 0.38 )
Ranked among companies with meaningful P/S only.
SEM' s P/S Range Over the Past 10 Years
Min: 0.24  Med: 0.44 Max: 0.7
Current: 0.38
0.24
0.7
PFCF 13.84
SEM's PFCF is ranked higher than
73% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. SEM: 13.84 )
Ranked among companies with meaningful PFCF only.
SEM' s PFCF Range Over the Past 10 Years
Min: 4.49  Med: 9.65 Max: 61.43
Current: 13.84
4.49
61.43
POCF 5.23
SEM's POCF is ranked higher than
88% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 14.37 vs. SEM: 5.23 )
Ranked among companies with meaningful POCF only.
SEM' s POCF Range Over the Past 10 Years
Min: 3.11  Med: 5.81 Max: 11.08
Current: 5.23
3.11
11.08
EV-to-EBIT 11.46
SEM's EV-to-EBIT is ranked higher than
82% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 20.23 vs. SEM: 11.46 )
Ranked among companies with meaningful EV-to-EBIT only.
SEM' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.9  Med: 10.6 Max: 15.4
Current: 11.46
7.9
15.4
EV-to-EBITDA 8.47
SEM's EV-to-EBITDA is ranked higher than
83% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 14.64 vs. SEM: 8.47 )
Ranked among companies with meaningful EV-to-EBITDA only.
SEM' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.2  Med: 8.3 Max: 12.3
Current: 8.47
6.2
12.3
PEG 1.24
SEM's PEG is ranked higher than
82% of the 74 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. SEM: 1.24 )
Ranked among companies with meaningful PEG only.
SEM' s PEG Range Over the Past 10 Years
Min: 0.5  Med: 1.41 Max: 8.7
Current: 1.24
0.5
8.7
Shiller P/E 16.21
SEM's Shiller P/E is ranked higher than
77% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 28.53 vs. SEM: 16.21 )
Ranked among companies with meaningful Shiller P/E only.
SEM' s Shiller P/E Range Over the Past 10 Years
Min: 10.14  Med: 14.83 Max: 17.64
Current: 16.21
10.14
17.64
Current Ratio 1.54
SEM's Current Ratio is ranked higher than
58% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. SEM: 1.54 )
Ranked among companies with meaningful Current Ratio only.
SEM' s Current Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.31 Max: 1.64
Current: 1.54
0.86
1.64
Quick Ratio 1.54
SEM's Quick Ratio is ranked higher than
64% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. SEM: 1.54 )
Ranked among companies with meaningful Quick Ratio only.
SEM' s Quick Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.31 Max: 1.64
Current: 1.54
0.86
1.64
Days Sales Outstanding 52.76
SEM's Days Sales Outstanding is ranked lower than
62% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 43.71 vs. SEM: 52.76 )
Ranked among companies with meaningful Days Sales Outstanding only.
SEM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.41  Med: 51.48 Max: 58.86
Current: 52.76
39.41
58.86
Days Payable 11.87
SEM's Days Payable is ranked lower than
84% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. SEM: 11.87 )
Ranked among companies with meaningful Days Payable only.
SEM' s Days Payable Range Over the Past 10 Years
Min: 11.87  Med: 14.95 Max: 17.85
Current: 11.87
11.87
17.85

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 0.79
SEM's Yield on cost (5-Year) is ranked lower than
80% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. SEM: 0.79 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SEM' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.79  Med: 2.55 Max: 3.48
Current: 0.79
0.79
3.48
3-Year Average Share Buyback Ratio 2.30
SEM's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. SEM: 2.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SEM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -34.6  Med: 3.75 Max: 0
Current: 2.3
-34.6
0

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.60
SEM's Price/Projected FCF is ranked higher than
91% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. SEM: 0.60 )
Ranked among companies with meaningful Price/Projected FCF only.
SEM' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.52  Med: 0.85 Max: 1.09
Current: 0.6
0.52
1.09
Price/Median PS Value 0.87
SEM's Price/Median PS Value is ranked higher than
72% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. SEM: 0.87 )
Ranked among companies with meaningful Price/Median PS Value only.
SEM' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 1 Max: 1.58
Current: 0.87
0.63
1.58
Price/Peter Lynch Fair Value 1.25
SEM's Price/Peter Lynch Fair Value is ranked higher than
77% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 2.33 vs. SEM: 1.25 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SEM' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.51  Med: 1.48 Max: 2.48
Current: 1.25
0.51
2.48
Earnings Yield (Greenblatt) (%) 8.76
SEM's Earnings Yield (Greenblatt) (%) is ranked higher than
86% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. SEM: 8.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SEM' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.5  Med: 9.4 Max: 12.7
Current: 8.76
6.5
12.7
Forward Rate of Return (Yacktman) (%) 17.00
SEM's Forward Rate of Return (Yacktman) (%) is ranked higher than
71% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.20 vs. SEM: 17.00 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SEM' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -3.3  Med: 10.2 Max: 30.1
Current: 17
-3.3
30.1

More Statistics

Revenue (TTM) (Mil) $4,246
EPS (TTM) $ 1.12
Beta1.65
Short Percentage of Float11.77%
52-Week Range $7.33 - 14.30
Shares Outstanding (Mil)131.47

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 4,292 4,471 4,721
EPS ($) 0.83 0.88 0.99
EPS w/o NRI ($) 0.83 0.88 0.99
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NYSE:SEM

Headlines

Articles On GuruFocus.com
UnitedHealth Group Reports Strong Second Quarter Earnings Results Jul 21 2015 
Ken Fisher's New Buys in Q1 Apr 30 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Weekly Highlight of CEO Sells Oct 13 2014 
Invesco’s Wilbur Ross, Real-Time and Review Nov 14 2013 
Distressed Investor Wilbur Ross Buys 2 Stocks May 16 2013 
My 4 High Dividend-Paying Favorites from the Share Buyback Achievers Index May 13 2013 
Select Medical Corp. Reports Operating Results (10-Q) Nov 12 2010 
Select Medical Corp. Reports Operating Results (10-Q) Aug 12 2010 
Select Medical Corp. Reports Operating Results (10-Q) May 14 2010 

More From Other Websites
21 September, 2016 | First Half Report Sep 21 2016
15 September, 2016 | Payment of Coupons Sep 15 2016
Concentra Inc. -- Moody's downgrades Concentra's first lien revolver and term loan to B2; affirms B2... Sep 12 2016
31 August, 2016 | Privileged Information - First Half Results Aug 31 2016
ETF’s with exposure to Select Medical Holdings Corp. : August 22, 2016 Aug 22 2016
Select Medical Holdings Corp. breached its 50 day moving average in a Bullish Manner : SEM-US :... Aug 19 2016
SELECT MEDICAL HOLDINGS CORP Financials Aug 12 2016
Select Medical Holdings Corp. :SEM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
ETF’s with exposure to Select Medical Holdings Corp. : August 9, 2016 Aug 09 2016
Select Medical Holdings Corp.: Strong price momentum but will it sustain? Aug 08 2016
Select Medical (SEM) Lags Q2 Earnings, Revises 2016 View Aug 08 2016
Select Medical Holdings Corp. breached its 50 day moving average in a Bullish Manner : SEM-US :... Aug 08 2016
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Change in Directors or Principal Officers Aug 05 2016
Edited Transcript of SEM earnings conference call or presentation 5-Aug-16 1:00pm GMT Aug 05 2016
Select Medical misses 2Q profit forecasts Aug 05 2016
Select Medical misses 2Q profit forecasts Aug 05 2016
August 4, 2016 - Select Medical Holdings Corporation Announces Results for Second Quarter Ended June... Aug 04 2016
SELECT MEDICAL HOLDINGS CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 04 2016
Kindred Healthcare Reports Second Quarter 2016 Results at High End of Guidance Range Aug 04 2016
SELECT MEDICAL HOLDINGS CORP Files SEC form 10-Q, Quarterly Report Aug 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)